亚斯巴甜促进卵巢癌的进展:一项综合孟德尔随机化,网络毒理学和体外验证的多omics研究
Qingquan Gong1, Dingyu Liang1, Yongjin Luo1
1Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
概括
人工甜味剂阿斯巴甜的摄入可能会增加卵巢癌 (OC) 的风险. 这项研究表明,阿斯巴甜可以通过调节AURKA,CCND1和RAD51.1等关键基因来促进OC发育.
科学领域:
- 在瘤学瘤学.
- 毒理学 毒理学 毒理学
- 遗传学 是一个遗传学.
背景情况:
- 消费阿斯巴甜和卵巢癌 (OC) 风险之间的联系尚不清楚.
- 调查潜在的因果关系对于公共卫生至关重要.
研究的目的:
- 探索阿斯巴甜摄入量与卵巢癌之间的因果关系.
- 为了阐明底层的分子机制.
主要方法:
- 门德尔随机化 (MR) 分析以评估遗传倾向.
- 网络毒理学与机器学习集成 (LASSO,SVM,随机森林).
- 多omics数据分析 (批量和单细胞RNA测序),分子对接和体外实验.
主要成果:
- 基因预测的阿斯巴甜摄入量与OC风险增加有关 (OR=2.10).
- AURKA,CCND1和RAD51被确定为潜在的核心点基因,在OC组织中进行上调.
- 阿斯巴甜在体外促进了OC细胞恶性表型,并调节了核心基因表达.
- 因果证据将CCND1表达与OC风险增加联系在一起.
结论:
- 阿斯巴甜可能会促进卵巢癌的发展.
- 潜在的机制包括对AURKA,CCND1和RAD51.1的调节.
- 这些发现有助于评估阿斯巴甜的安全性.
相关概念视频
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Oogenesis
68.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
In-vitro Mutagenesis
16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


